These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3889425)

  • 1. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 2. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
    Furusaki F; Sudo T; Tsutsui S
    Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of D Dimer analysis in blood coagulation and fibrinolysis tests].
    Kurokawa I; Kondo H
    Nihon Rinsho; 1989 Dec; 48 Suppl():901-5. PubMed ID: 2695675
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of D-dimer assays].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1989 Apr; Spec No 81():189-97. PubMed ID: 2666686
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new method for determination of DD/E complex using latex agglutination].
    Soe G; Kohno I; Motojima M; Saito M; Matsuda M; Terukina S
    Rinsho Byori; 1989 Apr; Spec No 81():176-82. PubMed ID: 2754805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
    Matsumoto T; Sakai Y; Maeda M; Takei F
    Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
    Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assays for fibrinogen-fibrin degradation products in biological fluids: some methodological aspects.
    Donati MB
    Thromb Diath Haemorrh; 1975 Dec; 34(3):652-60. PubMed ID: 1108282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N; Aoki Y; Terada H
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on latex agglutination test for fibrin degradation products (author's transl)].
    Isobe J; Hamai Y; Taharaguchi T; Watanabe H; Kusumoto M; Saito S
    Rinsho Byori; 1977 Oct; 25(10):843-7. PubMed ID: 599703
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantification of the fibrinogen degradation products FDP-D and FDP-E in blood, using immunoenzyme analysis].
    León VJ; León E; López Borrasca A
    Sangre (Barc); 1986; 31(1):23-30. PubMed ID: 3085242
    [No Abstract]   [Full Text] [Related]  

  • 17. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
    Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
    Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of fibrin-fibrinogen degradation products in the serum of newborn infants using a standardized hemagglutination inhibition test (the FDP kit)].
    Weitzel KH; Eschenbach C
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):23-8. PubMed ID: 6700599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical model for the agglutination reaction of FR antigens in a new latex photometric immunoassay with near infrared turbidimetry.
    Sudo T; Tsutsui S; Ito M; Morita S; Sawai M
    Kitasato Arch Exp Med; 1980 Jun; 53(1-2):55-68. PubMed ID: 7277958
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatoid factor interference with the latex agglutination test for fibrin degradation products.
    Rutstein JE; Holahan JR; Lyons RM; Pope RM
    J Lab Clin Med; 1978 Oct; 92(4):529-35. PubMed ID: 712192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.